# A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial

> **NCT06301308** · PHASE3 · WITHDRAWN · sponsor: **Second Xiangya Hospital of Central South University**

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Intraurethral lidocaine gel alone
- **DRUG:** Intraurethral lidocaine gel + lidocaine 2% injection
- **DRUG:** intraurethral lidocaine gel + liquid paraffinl

## Key facts

- **NCT ID:** NCT06301308
- **Lead sponsor:** Second Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-02-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The standard measures of anaesthesia in cystoscopy are not uniform internationally, and given this, we were unable to recruit the first participant in the study.
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06301308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06301308, "A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06301308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*